News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
884,021 Results
Type
Article (88790)
Company Profile (816)
Press Release (794393)
Multimedia
Podcasts (238)
Webinars (35)
Section
Business (233596)
Career Advice (4162)
Deals (39989)
Drug Delivery (177)
Drug Development (91711)
Employer Resources (207)
FDA (18555)
Job Trends (17487)
News (398743)
Policy (40014)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (3054)
Academic (2)
Accelerated approval (57)
ADA (49)
Adcomms (40)
Allergies (207)
Alliances (56990)
ALS (237)
Alzheimer's disease (1970)
Antibody-drug conjugate (ADC) (554)
Approvals (18901)
Artificial intelligence (871)
ASCO (345)
Autoimmune disease (362)
Automation (64)
Bankruptcy (407)
Best Places to Work (12635)
BIOSECURE Act (23)
Biosimilars (248)
Biotechnology (480)
Bladder cancer (211)
Brain cancer (85)
Breast cancer (840)
Cancer (6602)
Cardiovascular disease (556)
Career advice (3597)
Career pathing (52)
CAR-T (386)
CDC (76)
Celiac Disease (3)
Cell therapy (1074)
Cervical cancer (54)
Clinical research (79055)
Collaboration (2378)
Commercialization (1)
Company closure (8)
Compensation (1518)
Complete response letters (106)
COVID-19 (3041)
CRISPR (125)
C-suite (1288)
Cystic fibrosis (167)
Data (8745)
Decentralized trials (3)
Denatured (91)
Depression (194)
Dermatology (97)
Diabetes (708)
Diagnostics (7601)
Digital health (70)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (429)
Drug pricing (245)
Drug shortages (39)
Duchenne muscular dystrophy (319)
Earnings (102486)
Editorial (78)
Employer branding (25)
Employer resources (174)
Events (138711)
Executive appointments (1195)
FDA (22631)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1947)
Gene editing (272)
Generative AI (90)
Gene therapy (851)
GLP-1 (1286)
Government (5561)
Grass and pollen (8)
Guidances (420)
Healthcare (21264)
Hematology (198)
HIV (95)
Huntington's disease (64)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (115)
Immunology and inflammation (354)
Immuno-oncology (116)
Indications (208)
Infectious disease (3441)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (149)
Intellectual property (323)
Interviews (821)
IPO (18003)
IRA (61)
Job creations (5209)
Job search strategy (2871)
JPM (73)
Kidney cancer (23)
Labor market (122)
Layoffs (687)
Leadership (53)
Legal (10171)
Liver cancer (111)
Longevity (37)
Lung cancer (874)
Lymphoma (477)
Machine learning (66)
Management (66)
Manufacturing (1226)
Marketing (1)
MASH (226)
Medical affairs (1)
Medical device (15280)
Medtech (15441)
Mergers & acquisitions (23295)
Metabolic disorders (1831)
mRNA (267)
Multiple sclerosis (205)
NASH (24)
Neurodegenerative disease (510)
Neuropsychiatric disorders (128)
Neuroscience (3725)
Neurotech (2)
NextGen: Class of 2026 (7716)
Non-profit (5146)
Now hiring (80)
Obesity (873)
Opinion (374)
Ovarian cancer (245)
Pain (285)
Pancreatic cancer (355)
Parkinson's disease (417)
Partnered (40)
Patents (656)
Patient recruitment (764)
Peanut (71)
People (68015)
Pharmaceutical (136)
Pharmacy benefit managers (37)
Phase 1 (24435)
Phase 2 (34340)
Phase 3 (25824)
Pipeline (9804)
Policy (398)
Postmarket research (3560)
Preclinical (10986)
Press Release (72)
Prostate cancer (349)
Psychedelics (70)
Radiopharmaceuticals (373)
Rare diseases (1271)
Real estate (7462)
Recruiting (81)
Regulatory (30405)
Reports (77)
Research institute (2771)
Resumes & cover letters (654)
Rett syndrome (43)
RNA editing (30)
RSV (98)
Schizophrenia (197)
Series A (328)
Series B (239)
Service/supplier (28)
Sickle cell disease (128)
Special edition (32)
Spinal muscular atrophy (190)
Sponsored (55)
Startups (4372)
State (2)
Stomach cancer (21)
Supply chain (147)
Tariffs (104)
The Weekly (144)
Vaccines (1309)
Venture capital (134)
Weight loss (599)
Women's health (142)
Worklife (24)
Date
Today (135)
Last 7 days (633)
Last 30 days (2941)
Last 365 days (33294)
2026 (16384)
2025 (33218)
2024 (38123)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1297)
Alabama (102)
Alaska (7)
Arizona (403)
Arkansas (16)
Asia (52311)
Australia (9194)
California (14402)
Canada (4020)
China (1581)
Colorado (620)
Connecticut (641)
Delaware (447)
Europe (120640)
Florida (2140)
Georgia (467)
Hawaii (4)
Idaho (70)
Illinois (1255)
India (104)
Indiana (666)
Iowa (25)
Japan (597)
Kansas (143)
Kentucky (57)
Louisiana (64)
Maine (89)
Maryland (1749)
Massachusetts (10542)
Michigan (423)
Minnesota (802)
Mississippi (7)
Missouri (164)
Montana (37)
Nebraska (30)
Nevada (154)
New Hampshire (92)
New Jersey (3822)
New Mexico (35)
New York (3792)
North Carolina (1941)
North Dakota (11)
Northern California (7163)
Ohio (449)
Oklahoma (27)
Oregon (55)
Pennsylvania (2837)
Puerto Rico (30)
Rhode Island (55)
South America (1668)
South Carolina (88)
South Dakota (2)
Southern California (5650)
Tennessee (228)
Texas (2346)
United States (51555)
Utah (429)
Vermont (1)
Virginia (366)
Washington D.C. (89)
Washington State (1185)
West Virginia (4)
Wisconsin (160)
Wyoming (2)
There are 884,021 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pancreatic cancer
Elicio crashes on midstage pancreatic cancer miss but will advance to Phase 3
Elicio Therapeutics’ investigational cancer immunotherapy failed to meet the primary endpoint of disease-free survival in a Phase 2 trial—a result the company attributed mostly to a disproportionate number of patients with higher residual disease.
June 15, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Omeros Announces Webcast Details for Annual Meeting of Shareholders - June 15, 2026
June 15, 2026
·
2 min read
Press Releases
Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Demonstrating Improved Growth Measures in Pediatric Patients with Classic Congenital Adrenal Hyperplasia at ENDO 2026
June 15, 2026
·
16 min read
Press Releases
Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026
June 15, 2026
·
8 min read
Press Releases
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
June 15, 2026
·
10 min read
Press Releases
NewcelX Publishes Peer-Reviewed Study Demonstrating Broad Therapeutic Potential of its Stem Cell Technology Platform
June 15, 2026
·
6 min read
Press Releases
Sparrow Pharmaceuticals Announces Interim CAPTAIN-T2D Data Validating High Prevalence of Elevated Cortisol in Difficult-to-Control Type 2 Diabetes
June 15, 2026
·
4 min read
Press Releases
Fate Therapeutics Appoints Laura Hamill to Board of Directors
June 15, 2026
·
6 min read
Press Releases
Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
June 15, 2026
·
1 min read
Press Releases
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
June 15, 2026
·
9 min read
1 of 88,403
Next
